1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Idiopathic Parkinson Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bennett, SA; Figeys, D; Fraser, PE; Hou, W; Marsilio, D; Tandon, A; Visanji, NP; Whitehead, SN; Wislet-Gendebien, S | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Differential regulation of wild-type and mutant alpha-synuclein binding to synaptic membranes by cytosolic factors.
Topics: Adenosine Triphosphate; alpha-Synuclein; Animals; Blotting, Western; Brain Chemistry; Calcium; Cytosol; Genotype; Humans; Lipids; Membrane Proteins; Mice; Mice, Knockout; Mutation; Mutation, Missense; Parkinson Disease; Platelet Activating Factor; Protein Binding; Synaptic Membranes; Synaptosomes | 2008 |